SCHEMBL7806444

SCHEMBL7806444

COc1cccc(OC)c1/C=C/c1ccc(NC(C)=O)c(C(=O)O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.51
CYP1A1 P04798 1/20 0.51
CYP1B1 Q16678 1/20 0.51
KDM4E B2RXH2 5/20 0.49
ALDH1A1 P00352 4/20 0.49
HSD17B10 Q99714 4/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
TP53 P04637 2/20 0.49
CYP3A4 P08684 2/20 0.49
HPGD P15428 2/20 0.49
HIF1A Q16665 2/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
NPC1 O15118 1/20 0.49
ABCC4 O15439 1/20 0.49
HPGDS O60760 1/20 0.49
ABCB11 O95342 1/20 0.49
PKM P14618 1/20 0.49
ALOX12 P18054 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7806446 1.00 CYP1A2 (0.51) CYP1A2CYP1A1CYP1B1KDM4EALDH1A1
SCHEMBL7532470 0.82 PTPN1 (0.58) CYP1A2KDM4EALDH1A1HSD17B10MEN1
SCHEMBL7532475 0.82 PTPN1 (0.58) CYP1A2KDM4EALDH1A1HSD17B10MEN1
SCHEMBL7802340 0.80 CYP1A1 (0.55) CYP1A2CYP1A1CYP1B1KDM4EALDH1A1
SCHEMBL7529680 0.78 KDM4E (0.55) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL7529691 0.78 KDM4E (0.55) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL7524206 0.76 PTGS2 (0.52) CYP1A2KDM4EALDH1A1HSD17B10MEN1
SCHEMBL7524215 0.76 PTGS2 (0.52) CYP1A2KDM4EALDH1A1HSD17B10MEN1
SCHEMBL7796217 0.74 KDM4E (0.61) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL6673290 0.73 ABCB1 (0.55) CYP1A2KDM4EALDH1A1HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815087-B1 TRISUBSTITUTED PHENYL DERIVATIVES NOVARTIS AG (CH) 2001-11-14 EP disclosed
US-5990116-A USE IN PREVENTION OR TREATMENT OF INFLAMMATORY AND PROLIFERATIVE SKIN DISEASES AND CANCER; COMPOUNDS SUCH AS 6-(2-(2,5-DIMETHOXYPHENYL)ETHYL)-4-ETHYL-QUINAZOLINE NOVARTIS AG (CH) 1999-11-23 US disclosed
EP-0815087-A1 TRISUBSTITUTED PHENYL DERIVATIVES Novartis AG (CH) 1998-01-07 EP disclosed
WO-1996028430-A1 TRISUBSTITUTED PHENYL DERIVATIVES NOVARTIS AG (CH) 1996-09-19 WO disclosed